raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:621

Autosomal recessive methemoglobinemia

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy, Neonatal
Status
active

A rare red cell disorder classified principally into two clinical phenotypes: autosomal recessive congenital (or hereditary) methemoglobinemia types I and II (RCM/RHM type 1; RCM/RHM type 2).

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAutosomal recessive methemoglobinemia
frMéthémoglobinémie autosomique récessive
deMethämoglobinämie, autosomal-rezessive
esMetahemoglobinemia autosómica recesiva
itMetemoglobinemia autosomica recessiva
nlAutosomaal recessieve methemoglobinemie
ptMetahemoglobinemia autossómica recessiva
plMethemoglobinemia o dziedziczeniu autosomalnym recesywnymMethemoglobinemia wrodzona · Autosomalna recesywna methemoglobinemia
csHereditární methemoglobinémie
ukСпадкова метгемоглобінеміяАутосомно-рецесивна метгемоглобінемія · Вроджена метгемоглобінемія
zh遗传性高铁血红蛋白血症常染色体隐性高铁血红蛋白血症
trKalıtsal methemoglobinemiDoğumsal methemoglobinemi · Otozomal Çekinik methemoglobinemi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM250700BTNTvalidated
OMIM250790BTNTvalidated
OMIM250800BTNTvalidated
ICD-10D74.0NTBTattributedvalidated
MONDO0018963Evalidated
MeSHC580280Evalidated
UMLSC0272087Evalidated
GARD2659Evalidated
MedDRA10010543Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

Codes that Orphanet moved or referred to this one:

4

Genes

2 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CYB5ACandidate gene tested inNot yet assessedHGNC:2570ENSG0000016634761321818q22.3cytochrome b5 type A
CYB5R3Disease-causing germline mutation(s) inAssessedHGNC:2873ENSG0000010024361321322q13.2cytochrome b5 reductase 318820099[PMID]_18202104[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

26 annotations · validated 2019-10-09
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0000961Cyanosis
HP:0012119Methemoglobinemia
Frequent (79-30%)
HP:0001597Abnormal nail morphology
HP:0000707Abnormality of the nervous system
HP:0002875Exertional dyspnea
HP:0025118Lip discoloration
Occasional (29-5%)
HP:0002305Athetosis
HP:0000592Blue sclerae
HP:0001272Cerebellar atrophy
HP:0006808Cerebral hypomyelination
HP:0000565Esotropia
HP:0006913Frontal cortical atrophy
HP:0002283Global brain atrophy
HP:0001263Global developmental delay
HP:0010864Intellectual disability, severe
HP:0002451Limb dystonia
HP:0000252Microcephaly
HP:0011344Severe global developmental delay
HP:0002510Spastic tetraplegia
HP:0001257Spasticity
HP:0007112Temporal cortical atrophy
Very rare (<4-1%)
HP:0012448Delayed myelination
HP:0001276Hypertonia
HP:0001250Seizure
HP:0012697Small basal ganglia
HP:0001518Small for gestational age

Run the differential on the 2 obligate / very frequent terms

Annotation source: 24266649[PMID]_29482478[PMID]_10874300[PMID]_7718898[PMID]_9695975[PMID]

7

Sources for this card